Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Ret Proto-Oncogene antibody

RET Reactivity: Human, Mouse WB, IHC (p), IF Host: Mouse Monoclonal 8C3 unconjugated
Catalog No. ABIN4913582
  • Target See all Ret Proto-Oncogene (RET) Antibodies
    Ret Proto-Oncogene (RET)
    Reactivity
    • 152
    • 93
    • 73
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Mouse
    Host
    • 176
    • 22
    • 2
    • 2
    • 1
    • 1
    Mouse
    Clonality
    • 175
    • 29
    Monoclonal
    Conjugate
    • 87
    • 13
    • 11
    • 9
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    This Ret Proto-Oncogene antibody is un-conjugated
    Application
    • 168
    • 84
    • 65
    • 65
    • 40
    • 27
    • 17
    • 16
    • 13
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)
    Cross-Reactivity
    Human, Mouse
    Purification
    Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.
    Immunogen
    This RET Monoclonal antibody was raised using purified His-tagged recombinant human RET.
    Clone
    8C3
    Isotype
    IgM
    Top Product
    Discover our top product RET Primary Antibody
  • Application Notes
    WB 1:300-5000
    IHC-P 1:200-400
    IF()
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C for 12 months.
    Expiry Date
    12 months
  • Target
    Ret Proto-Oncogene (RET)
    Alternative Name
    RET (RET Products)
    Background

    Synonyms: PTC, MTC1, HSCR1, MEN2A, MEN2B, RET51, CDHF12, CDHR16, RET-ELE1, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, RET

    Background: Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis, involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor, in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers, these diseases are characterized by aberrant integrins-regulated cell migration.

    Gene ID
    5979
    UniProt
    P07949
    Pathways
    RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
You are here:
Support